OUR VALUES

Engagement

Respect

Integrity

Innovation
OUR EXPERTISE
Since its foundation in 2012, VaxTRIALS has been involved in more than 50 vaccine-related clinical, epidemiological and health economics trials throughout the Latin American region, helping clients, sponsors, and vendors to achieve extraordinary results in implementation of their studies. Since then, we have had the opportunity to be involved in different clinical trials for the prevention of diseases like Chikungunha, Covid-19, Influenza, Dengue, Hepatitis A, Meningitis, Norovirus, Norovirus EPI, Herpes Zoster, Pertussis, RSV and Polio in different countries of Latin America, such as Panama, Colombia, Guatemala, Dominican Republic, Costa Rica, Uruguay, Brazil, Argentina, Ecuador, Paraguay and Chile.
In total, through a vast network of highly skilled, trained and leading investigators across the region, VaxTRIALS has contributed to the recruitment of more than 38,000 subjects and 320,000 study visits. With our solutions, we optimize clinical vaccine trial timeframes by promoting faster patient enrollment and higher adherence.
partnerSHIPS
As a key player in Latin America, we have long-lasting partnerships with local and regional/global partners and vendors including, but not limited to, IT solutions, Pharmacovigilance Service Companies, Biostatistics, Epidemiology, Data Management, Translation Services, Medical Writing, Import & Export, Supplies, Handling, Storage and Shipment of Investigational Product.
OUR CLIENTS
Great value for everyone involved, through strong relationships and engaged vendors, investigators and site networks.
Our previous and current sponsor and partners include NGOs, foundations, big & small pharma and biotech, and manufacturers.
FOUNDATIONS AND NGOS






PHARMACEUTICAL INDUSTRY
















STATE INSTITUTIONS

CRO PARTNERS






TOGETHER WE MAKE IT POSSIBLE WITH OUR CLIENTS!
OUR PEOPLE
EXECUTIVE COMMITTEE & MANAGEMENT TEAM
Our team is composed of motivated professionals with educational background in life sciences, bilingual, many of them with ample experience in vaccine research and/or the pharmaceutical industry.

Tom Herremans, COO
Master of Science, MBA, PMP certified. More than 20 years of experience in the vaccine industry, mainly at (GSK) in global and local positions. He has led small and large teams and defined the asset's mission, vision, and strategic objectives for different clinical vaccine development and commercialization projects & programs.

Pablo Díaz, CFO
Economist, Master un Corporate Finance, and more than 15 years of experience in the Financial, Consumer and Industrial sectors in Multinational companies. Broad experience leading Financial Teams as Business Finance, Controller and CFO. Pablo has led Business Model transformations, Digital Startups and Strategic Planning Consultancy projects in diverse sectors in Colombia.

Paula Casasco,
Quality & Training Head
Molecular Biologist with an MBA and a fellowship at NIDR, NIH. She is a Registered Quality Consultant professional in GCP (RQAP-GCP) with more than 20 years of experience in the Pharmaceutical, Biotech and Medical Devices industries, including extensive experience in multi-center regional project management, and GCP training and auditing of Phase I–IV clinical studies.

Cristina Gómez, CHRO
Master in strategic Thinking and Psychologist. More than 13 years of experience in Human Resources in Pharma Industry in local and regional positions across Latin America. Before Vax, she worked for more than 3 years in Sanofi for Colombia, Perú, Panamá and Central America as Human Resources Business Partner. Cristina has led different HR projects Related to Change Management, Culture Transformation, Talent Management and Strategic Worforce Planning.

Luz Elena Moreno,
Medical and Pharmacovigilance Director
Medical doctor, epidemiologist, and master´s degree in health economics. More than 15 years of experience working in medical affairs departments for pharmaceutical companies. Extensive knowledges in the development and leadership of the medical strategy for different therapeutic areas mainly in vaccine, identification and design of engagement plan with external experts and other relevant stakeholders, medical leadership of evidence generation and clinical studies activities and scientific activities planning and execution.